Duchenne muskuler distrofisi tanısı olan çocukların yaşam ve uyku kaliteleri ile annelerinin anksiyete düzeyi: Bir olgu kontrol çalışması

Amaç: Duchenne musküler distrofi (DMD) birçok musküler distrofi arasında en ciddi olanıdır. DMD'nin etyolojisi ve patofizyolojisi üzerine yapılan araştırmalardaki hızlı ilerleyişe rağmen, tedavisi henüz mümkün değildir. DMD gibi ciddi kronik bir hastalığın varlığı hem hastalar hem de bakımverenler üzerinde büyük etkilere sebep olabilir. Biz bu çalışmada DMD tanılı olgular ile sağlıklı kontrollerin yaşam ve uyku kalitesini karşılaştırmayı aynı zamanda olgu ve kontrollerin annelerinin de anksiyete düzeyini değerlendirmeyi planladık.Yöntem: Çalışmaya 17 DMD tanılı olgu ile 20 sağlıklı kontrol dahil edilmiştir. Olgu ve kontrollerin hepsi erkektir. Olgu ve kontrollerin sosyal durumu sosyodemografik veri formu ile değerlendirilmiştir. Çocukların yaşam kalitelerini değerlendirmek için çocuklar ve ebeveynleri tarafından doldurulan Çocuklar için Yaşam Kalitesi Ölçeği (ÇİYKÖ) kullanılmıştır. Pittsburg Uyku Kalitesi İndeksi (PUKİ) çocukların uyku kalitesini değerlendirmek için kullanılan bir özbildirim ölçeğidir. Annelerin anksiyetesi Durumluk- Süreklilik Anksiyete Ölçeği (STAI)-durumluk ve süreklilik formları ile değerlendirilmiştir. Mann Whitney U ve kikare istatistiksel analiz olarak kullanılmıştır.Bulgular:: Olgu ve kontrollerin hem ÇİYKÖ ebeveyn hem ÇİYKÖ çocuk formları kıyaslandığında istatistiksel anlamlı fark bulunmuştur. Olgu ve kontrollerin uyku kalitesi arasındaki fark da istatistiksel olarak anlamlı çıkmıştır. STAI durumluk ve süreklilik ölçeklerinde olgu ve kontrollerin annelerinin anksiyete düzeyleri arasında anlamlı fark bulunmamıştır.Sonuç: Bizim çalışmamızın temel bulgusu DMD'li olguların uykuda daha fazla zorlukları olduğu ve yaşam kalitelerinin sağlıklı kontrollere göre daha düşük olduğudur. Motor işlevsellikteki zorlukların duygusal, sosyal işlevselliğe ve belki de çocukların uyku kalitesine etkileri olabilir

Quality of Life and Sleep in Children Diagnosed with Duchenne Muscular Dystrophy and Their Mothers’ Level of Anxiety: A Case- Control Study

Objective: Duchenne Muscular Dystrophy (DMD) is the most severe form among a variety of muscular dystrophies. While studies into the etiology and pathophysiology of DMD have progressed fast, there still is no therapy for the disease. The presence of a severe chronic disease such as DMD can seriously affect patients as well as caregivers. In this study, we planned to compare quality of life and sleep between cases diagnosed as DMD and healthy controls while at the same time assessing the levels of anxiety in the patients’ mothers.Method: In this study, 17 cases with a diagnosis of DMD and 20 healthy controls were enrolled. All the patients and controls were male. The social status of patients and controls was assessed with a sociodemographic data form. To evaluate the children’s quality of life, the Pediatric Quality of Life Inventory (PedsQL) was completed by children and parents. The Pittsburgh Sleep Quality Index (PSQI) is a selfreported questionnaire used to evaluate the quality of sleep in children. We measured the mothers’ anxiety with the State-Trait Anxiety Inventory (STAI) - state anxiety and trait anxiety forms. Mann-Whitney U test and chi square test were used for statistical analysis.Results: A statistically significant difference was found in comparing both parents’ and children’s PedsQL forms between patients and controls. The quality of sleep also differed significantly between cases and controls. In the STAI state and trait anxiety forms, no significant difference was found between the anxiety levels of patients’ mothers and the control persons’ mothers. Conclusion: As key result of our study, we found that there are more problems in the DMD patients’ sleep, and the quality of life is lower than in the healthy controls. Problems in motor functionality may affect emotional and social functionality and possibly the quality of children’s sleep

___

  • 1. Billard C, Gillet P, Barthez M, Hommet C, Bertrand P. Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy. Dev Med Child Neurol 1998; 40:12-20. [CrossRef]
  • 2. Pearson R, van Ommen G. Recent Developments in DNA Research of Duchenne Muscular Dystrophy. In: Pearson KP, Stadhouders A (editors). Research into the Origin and Treatment of Muscular Dystrophy. Amsterdam, The Netherlands: Excerpta Medica, 1984, 91-100.
  • 3. Mendel JR, Griggs RC, Ptacek LJ. Diseases of Muscle. In Fauci AS, Braunwald E, Isselbacher KJ, et al., (editors). Harrison’s Principles of Internal Medicine. New York: McGraw-Hill, 1998, 2473-2483.
  • 4. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002; 12:926- 929. [CrossRef]
  • 5. Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O’Neill R, Kennedy DL. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007; 10(Suppl 2):S125-S137. [CrossRef]
  • 6. Meltzer LJ. Mothers of children with chronic illnesses: A caregiver burden model and summer camp as respite care. Ph.D. dissertation, United States-Florida, University of Florida, 2002.
  • 7. Cavusoglu H. Pediatric Nursing. Expanded Eighth ed., Ankara: Sistem Ofset Basımevi, 2004, 71-86. (Turkish)
  • 8. Eiser C, Morse R. Can parents rate their child’s health-related quality of life? Results of a systematic review. Qual Life Res 2001; 10:347-357. [CrossRef]
  • 9. Petersen C, Schmidt S, Power M, Bullinger M; DISABKIDS Group. Development and pilot-testing of a health-related quality of life chronic generic module for children and adolescents with chronic health conditions: a European perspective. Qual Life Res 2005; 14:1065-1077. [CrossRef]
  • 10. Bingol N. Evaluation of the relationship between the sleep quality of nurses and their job satisfaction levels. Post Graduate Thesis, Cumhuriyet University, Sivas, 2006. (Turkish)
  • 11. Fadiloglu C, Ilkbay Y, Yildirim-Kuzeyli Y. Sleep quality of nursing home residents. Turkish Journal of Geriatrics 2006; 9:165-169. (Turkish)
  • 12. Kiper S, Sunal N. Evaluation of sleep quality in rheumatoid arthritis patients. The Medical Journal of Kocatepe 2009; 10:33- 39. (Turkish)
  • 13. Colbay M, Yuksel S, Fidan F, Acarturk G, Karaman O, Unlu M. Evaluation of the hemodialysis patient with Pittsburgh sleep quality index. Tuberculosis and Thorax 2007; 55:167-173. (Turkish)
  • 14. Er DM. Child, illness, parent siblings. Cocuk Sagligi ve Hastaliklari Dergisi 2006; 49:155-168. (Turkish)
  • 15. Ozsenol F, Isikhan V, Unay B, Aydin HI, Akin R, Gokcay E. The evaluation of family functions of families with handicapped children. Gulhane Medical Journal 2003; 45:156-164. (Turkish)
  • 16. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999; 37:126-139. [CrossRef]
  • 17. Varni JW, Seid M, Kurtin PS. PedsQLTM 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001; 39:800-812. [CrossRef]
  • 18. Uneri O. The validity and reliability of Pediatric Quality of Life Inventory in 2-7 years old Turkish children. Unpublished Thesis, Kocaeli University Faculty of Medicine, Kocaeli, 2005. (Turkish)
  • 19. Cakin-Memik N, Agaoglu B, Coskun A, Uneri OS, Karakaya I. The validity and reliability of Turkish Pediatric Quality of Life Inventory in 13-18 years old Turkish children. Turk Psikiyatri Derg 2007; 18:353-363.
  • 20. Cakin-Memik N, Agaoglu B, Coskun A, Uneri OS, Karakaya I. The validity and reliability of Pediatric Quality of Life Inventory in 8-12 years old Turkish children. Turkish Journal of Child and Adolescent Mental Health 2008; 15:87-99. (Turkish)
  • 21. Spielberger CD, Gorsuch RL, Lushene RE. Manual for State-Trait Anxiety Inventory. California Consulting Psychologist Press, 1970.
  • 22. Oner N, Le Compte A. Manual for the State-Trait Anxiety Inventory. Bosphorus University Press, Istanbul, 1983. (Turkish)
  • 23. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28:193- 213. [CrossRef]
  • 24. Agargun MY, Kara H, Anlar O. The validity and reliability of the Pittsburgh Sleep Quality Index. Turk Psikiyatri Derg 1996; 7:107- 111. (Turkish)
  • 25. McDonald CM, McDonald DA, Bagley A, Sienko Thomas S, Buckon CE, Henricson E, Nicorici A, Sussman MD. Relationship between clinical outcome measures and parent proxy reports of health-related quality of life in ambulatory children with Duchenne muscular dystrophy. J Child Neurol 2010; 25:1130- 1144. [CrossRef]
  • 26. Baiardini I, Minetti C, Bonifacino S, Porcu A, Klersy C, Petralia P, Balestracci S, Tarchino F, Parodi S, Canonica GW, Braido F. Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. J Child Neurol 2011; 26: 707- 713. [CrossRef]
  • 27. Uzark K, King E, Cripe L, Spicer R, Sage J, Kinnett K, Wong B, Pratt J, Varni JW. Health-related quality of life in children and adolescents with Duchenne muscular dystrophy. Pediatrics 2012;130:e1559-e1566.
  • 28. Elsenbruch S, Schmid J, Lutz S, Geers B, Schara U. Self-reported quality of life and depressive symptoms in children, adolescents, and adults with Duchenne muscular dystrophy: a cross-sectional survey study. Neuropediatrics 2013; 44:257-264. [CrossRef]
  • 29. Abdulkadiroglu Z, Bayramoglu F, Ilhan N. Sleep and sleep disorders. Genel Tip Dergisi 1997; 7:161-166. (Turkish)
  • 30. Koulouglioti C, Cole R, Kitzman H. Inadequate sleep and unintentional injuries in young children. Public Health Nurs 2008; 25:106-114. [CrossRef]
  • 31. Wolfson AR, Carskadon MA. Sleep schedules and daytime functioning in adolescents. Child Dev 1998; 69:875-887. [CrossRef]
  • 32. Bootzin RR, Stevens SJ. Adolescents, substance abuse, and the treatment of insomnia and daytime sleepiness. Clin Psychol Rev 2005; 25:629-644. [CrossRef]
  • 33. Webb CL. Parents’ perspectives on coping with Duchenne muscular dystrophy. Child Care Health Dev 2005; 31:385-396. [CrossRef]
  • 34. Beresford BA. Resources and strategies: how parents cope with the care of a disabled child. J Child Psychol Psychiatry 1994; 35:171-209. [CrossRef]
  • 35. Rubin S. The Psychological Impact of Genetic Disease. In: Charash L, Lovelace R, Wolf S, Kutscher A, Roye D, Leach C, editors. Realities in Coping with Progressive Neuromuscular Diseases. Philadelphia: The Charles Press, 1987, 209-215.
  • 36. Thompson RJ Jr, Zeman JL, Fanurik D, Sirotkin-Roses M. The role of parent stress and coping and family functioning in parent and child adjustment to Duchenne muscular dystrophy. J Clin Psychol 1992; 48:11-19. [CrossRef]
  • 37. Cakaloz B, Kurul S. The investigation of Duchenne muscular dystrophy children’s family functions and their mothers’ depression and anxiety levels. Klinik Psikiyatri 2005; 8:24-30. (Turkish)
  • 38. Minnes PM. Family resources and stress associated with having a mentally retarded child. Am J Ment Retard 1988; 93:184-192. 39. Pelchat D, Ricard N, Bouchard JM, Perreault M, Saucier JF, Berthiaume M, Bisson J. Adaptation of parents in relation to their 6-month-old infant’s type of disability. Child Care Health Dev 1999; 25:377-397. [CrossRef
Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi-Cover
  • ISSN: 1018-8681
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1984
  • Yayıncı: Kare Yayıncılık